Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62021TA0149

    Case T-149/21: Judgment of the General Court of 2 March 2022 — UGA Nutraceuticals v EUIPO — Vitae Health Innovation (VITADHA) (EU trade mark — Opposition proceedings — International registration designating the European Union — Word mark VITADHA — Earlier Spanish word mark VITANADH — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

    OJ C 171, 25.4.2022, p. 31–31 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
    OJ C 171, 25.4.2022, p. 26–26 (GA)

    25.4.2022   

    EN

    Official Journal of the European Union

    C 171/31


    Judgment of the General Court of 2 March 2022 — UGA Nutraceuticals v EUIPO — Vitae Health Innovation (VITADHA)

    (Case T-149/21) (1)

    (EU trade mark - Opposition proceedings - International registration designating the European Union - Word mark VITADHA - Earlier Spanish word mark VITANADH - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

    (2022/C 171/40)

    Language of the case: English

    Parties

    Applicant: UGA Nutraceuticals Srl (Gubbio, Italy) (represented by: M. Riva, J. Graffer and A. Ottolini, lawyers)

    Defendant: European Union Intellectual Property Office (represented by: A. Folliard-Monguiral, acting as Agent)

    Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Vitae Health Innovation, SL (Montmeló, Spain) (represented by: E. Torner Lasalle, lawyer)

    Re:

    Action brought against the decision of the Fourth Board of Appeal of EUIPO of 15 January 2021 (Case R 2719/2019-4), relating to opposition proceedings between Vitae Health Innovation and UGA Nutraceuticals.

    Operative part of the judgment

    The Court:

    1.

    Dismisses the action;

    2.

    Orders UGA Nutraceuticals Srl to pay the costs.


    (1)  OJ C 182, 10.5.2021.


    Top